sprucekey9
About
The effects with the triazene compound CT913 about ovarian cancer malignancy cellular material throughout vitro and it is complete discussion with the PARP-inhibitor olaparib.
The effects with the triazene compound CT913 about ovarian cancer malignancy cellular material throughout vitro and it is complete discussion with the PARP-inhibitor olaparib.